300 related articles for article (PubMed ID: 28103424)
1. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
[TBL] [Abstract][Full Text] [Related]
2. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan.
Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):43-50. PubMed ID: 24353071
[TBL] [Abstract][Full Text] [Related]
3. Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC alone.
Lian M; Li B; Xiao X; Yang Y; Jiang P; Yan L; Sun C; Zhang J; Wei Y; Li Y; Chen W; Jiang X; Miao Q; Chen X; Qiu D; Sheng L; Hua J; Tang R; Wang Q; Eric Gershwin M; Ma X
Autoimmun Rev; 2017 Aug; 16(8):875-882. PubMed ID: 28564616
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
Mendes FD; Jorgensen R; Keach J; Katzmann JA; Smyrk T; Donlinger J; Chari S; Lindor KD
Am J Gastroenterol; 2006 Sep; 101(9):2070-5. PubMed ID: 16879434
[TBL] [Abstract][Full Text] [Related]
5. Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Venkatesh PG; Choudhary M; Shen B; Kiran RP
J Crohns Colitis; 2013 Mar; 7(2):e35-41. PubMed ID: 22554774
[TBL] [Abstract][Full Text] [Related]
6. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
7. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
[TBL] [Abstract][Full Text] [Related]
8. Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis.
Moon SH; Kim MH; Lee JK; Baek S; Woo YS; Cho DH; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2017 Apr; 52(4):483-493. PubMed ID: 27470434
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features, Response to Treatment, and Outcomes of IgG4-Related Sclerosing Cholangitis.
Tanaka A; Tazuma S; Okazaki K; Nakazawa T; Inui K; Chiba T; Takikawa H
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):920-926.e3. PubMed ID: 28111336
[TBL] [Abstract][Full Text] [Related]
10. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of IgG4-related sclerosing cholangitis.
Nakazawa T; Naitoh I; Hayashi K; Miyabe K; Simizu S; Joh T
World J Gastroenterol; 2013 Nov; 19(43):7661-70. PubMed ID: 24282356
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis.
Smolka V; Karaskova E; Tkachyk O; Aiglova K; Ehrmann J; Michalkova K; Konecny M; Volejnikova J
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):412-8. PubMed ID: 27498582
[TBL] [Abstract][Full Text] [Related]
13. The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis.
Benito de Valle M; Müller T; Björnsson E; Otten M; Volkmann M; Guckelberger O; Wiedenmann B; Sadik R; Schott E; Andersson M; Berg T; Lindkvist B
Dig Liver Dis; 2014 Oct; 46(10):903-8. PubMed ID: 25091876
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intraductal ultrasonography findings between primary sclerosing cholangitis and IgG4-related sclerosing cholangitis.
Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Ohara H; Joh T
J Gastroenterol Hepatol; 2015 Jun; 30(6):1104-9. PubMed ID: 25594435
[TBL] [Abstract][Full Text] [Related]
15. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
16. Clinical profiles of patients with primary sclerosing cholangitis in the elderly.
Tanaka A; Tazuma S; Okazaki K; Tsubouchi H; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2015 Mar; 22(3):230-6. PubMed ID: 25408495
[TBL] [Abstract][Full Text] [Related]
17. Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells.
Koyabu M; Uchida K; Fukata N; Kusuda T; Ikeura T; Sakaguchi Y; Yoshida K; Shimatani M; Fukui T; Matsushita M; Uemura Y; Kaibori M; Takaoka M; Nishio A; Okazaki K
J Gastroenterol; 2010; 45(1):122-9. PubMed ID: 19760481
[TBL] [Abstract][Full Text] [Related]
18. Review of primary sclerosing cholangitis with increased IgG4 levels.
Manganis CD; Chapman RW; Culver EL
World J Gastroenterol; 2020 Jun; 26(23):3126-3144. PubMed ID: 32684731
[TBL] [Abstract][Full Text] [Related]
19. The importance of IgG4 screening in patients diagnosed with primary sclerosing cholangitis in the past: A case rediagnosed as IgG4-SC after 10 years.
Li Y; Zhou L; Zhao X; Song W; Karunaratna N; Wang B
Medicine (Baltimore); 2016 Dec; 95(50):e5628. PubMed ID: 27977604
[TBL] [Abstract][Full Text] [Related]
20. Primary sclerosing cholangitis with moderately elevated serum-IgG4 - characterization and outcome of a distinct variant phenotype.
Zhou T; Lenzen H; Dold L; Bündgens B; Wedemeyer H; Manns MP; Gonzalez-Carmona MA; Strassburg CP; Weismüller TJ
Liver Int; 2021 Dec; 41(12):2924-2933. PubMed ID: 34328259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
